JPS6244915B2 - - Google Patents

Info

Publication number
JPS6244915B2
JPS6244915B2 JP55026762A JP2676280A JPS6244915B2 JP S6244915 B2 JPS6244915 B2 JP S6244915B2 JP 55026762 A JP55026762 A JP 55026762A JP 2676280 A JP2676280 A JP 2676280A JP S6244915 B2 JPS6244915 B2 JP S6244915B2
Authority
JP
Japan
Prior art keywords
ustilago
coq
ifo
coenzyme
produce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55026762A
Other languages
Japanese (ja)
Other versions
JPS56124390A (en
Inventor
Teruo Watanabe
Kazuyuki Myagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIC Corp
Original Assignee
Dainippon Ink and Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Ink and Chemicals Co Ltd filed Critical Dainippon Ink and Chemicals Co Ltd
Priority to JP2676280A priority Critical patent/JPS56124390A/en
Publication of JPS56124390A publication Critical patent/JPS56124390A/en
Publication of JPS6244915B2 publication Critical patent/JPS6244915B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】 本発明は担子菌による補酵素Q10(以下
「CoQ10」と略称する)の製造法に関するもので
ある。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing coenzyme Q 10 (hereinafter abbreviated as "CoQ 10 ") using basidiomycetes.

CoQ10は、下記の式で示されるキノン核の6位
にイソプレン側鎖を有する2,3−ジメトキシ−
5−メチル−1,4−ベンゾキノンでイソプレン
単位の数が10の化合物である。
CoQ 10 is a 2,3-dimethoxy-
It is a 5-methyl-1,4-benzoquinone compound with 10 isoprene units.

CoQ10は動植物、微生物細胞中のミトコンドリ
アに主として存在し、細胞内における末端電子伝
達系の重要因子として知られているが、近年、医
薬としてもその特性が注目され、うつ血性心不全
の治療を始めとして多くの臨床効果が報告されつ
つあり、今後その医薬としての用途の拡大が期待
されている。
CoQ 10 mainly exists in the mitochondria of animals, plants, and microbial cells, and is known to be an important factor in the terminal electron transport chain within cells.In recent years, its properties have attracted attention as a medicine, and it has been used for treatments such as congestive heart failure. Many clinical effects are being reported, and its use as a medicine is expected to expand in the future.

CoQ10は、現在合成法による製造も試みられて
いるが、前記のような複雑な構造を有するため、
CoQ10を工業的に生産する場合、製造コスト、製
造工程、収率の全てを満足しうることは困難で、
発酵法による製造法が再認識されている。
Currently, attempts are being made to produce CoQ 10 by synthetic methods, but due to its complex structure as described above,
When producing CoQ 10 industrially, it is difficult to satisfy all aspects of manufacturing cost, manufacturing process, and yield.
Production methods using fermentation methods are being rediscovered.

発酵法によるCoQ10の製造法としては、従来、
紅色光合成細菌であるロードシユードモナス・カ
プシユラタスによる方法(特公昭48−21519)、ロ
ードトルラ、クリプトコツカス、スポロボロマイ
セスに属る酵母による方法(特公昭48−8836)等
が公知であるが、これら細菌、酵母菌を利用した
場合でも、菌体増殖速度が遅く原料菌体の培養に
時間がかかる、CoQ10の菌体内生成量が低いなど
の理由でCoQ10を工業的規模で生産するには問題
が多い。
Conventional methods for producing CoQ 10 using fermentation methods include
Methods using the purple photosynthetic bacterium Rhodoseudomonas capsulatus (Japanese Patent Publication No. 48-21519), methods using yeasts belonging to Rhodotorula, Cryptococcus, and Sporobolomyces (Japanese Patent Publication No. 48-8836), etc. are known. Even when these bacteria and yeast are used, it is difficult to produce CoQ 10 on an industrial scale due to the slow growth rate of the bacteria, the time it takes to cultivate the raw material, and the low amount of CoQ 10 produced within the bacteria. has many problems.

そこで、本発明者らはさらにすぐれた発酵法に
よるCoQ10の製造法について種々検討した結果、
ウスチラゴ属に属する担子菌類が著量のCoQ10
産能を有していることを見出し、本発明に到達し
た。
Therefore, the present inventors investigated various methods for producing CoQ 10 using an even better fermentation method, and found that
The present invention was achieved by discovering that Basidiomycetes belonging to the genus Ustilago have a remarkable ability to produce CoQ 10 .

即ち、本発明の要旨は、ウスチラゴ属に属し、
CoQ10を生産する能力を有する担子菌を栄養培地
に培養してCoQ10を生成せしめ、得られた菌体よ
りこれを採取することを特徴とする発酵法による
CoQ10の製造法である。
That is, the gist of the present invention belongs to the genus Ustilago,
By a fermentation method characterized by culturing a basidiomycete having the ability to produce CoQ 10 in a nutrient medium to produce CoQ 10 , and collecting it from the resulting bacterial cells.
This is a method for producing CoQ 10 .

なお、ウスチラゴ属に属する担子菌によるCoQ
の生成については既に、ウスチラゴ・ゼア
(Ustilago zeae)が公知である(J.Biol.
Chem.234巻、2169頁1959年)が菌体内に蓄積さ
れるCoQの量も痕跡程度であり、またCoQのイソ
プレン単位数も明らかではない。従つて、ウスチ
ラゴ属に属する担子菌がCoQ10生成能を有するこ
と、該担子菌をCoQ10の発酵生産に利用しうるこ
とは、従来全く知られておらず、本発明はかかる
新規な知見にもとづくものである。
In addition, CoQ caused by basidiomycetes belonging to the genus Ustilago
Ustilago zeae is already known for its production (J. Biol.
Chem. Vol. 234, p. 2169, 1959), the amount of CoQ accumulated in the bacterial cells is only a trace, and the number of isoprene units in CoQ is not clear. Therefore, it has not been previously known that the basidiomycetes belonging to the genus Ustilago have the ability to produce CoQ 10 , and that the basidiomycetes can be used for the fermentation production of CoQ 10 , and the present invention is based on this new knowledge. It is based on

本発明に使用する微生物としては、ウスチラゴ
属に属しCoQ10生産菌ならば野生株、変異株のい
ずれもが使用でき、代表例としてウスチラゴ・シ
ノドンテイスIFO−9758、ウスチラゴ・エスクレ
ンタIFO−9887、ウスチラゴ・マイデイスIFO−
6907、ウスチラゴ・クサノイIFO−9070、ウスチ
ラゴ・ラベンホルスチアナIFO−8995の公知菌を
挙げることができる。
As the microorganisms used in the present invention, both wild strains and mutant strains of CoQ 10- producing bacteria belonging to the genus Ustilago can be used. Representative examples include Ustilago synodontheis IFO-9758, Ustilago esculenta IFO-9887, and Ustilago esculenta IFO-9887. My Days IFO−
6907, Ustilago cusanoi IFO-9070, and Ustilago labenhorstiana IFO-8995.

本発明で担子菌を培養するに際して栄養培地に
添加する炭素源としては、同化しうるものであれ
ばいかなるものでもよく、例えば、グルコース、
シユークロース、糖蜜、亜硫酸、パルプ廃液、木
材糖化液等の糖類;酢酸、クエン酸等の有機酸
類;メタノール、エタノール等のアルコール類;
液状炭化水素類、油脂及び脂肪類、グリセリン等
が使用できる。窒素源としては硫安、塩安、リン
酸アンモン、アンモニア、尿素、ペプトン、カゼ
イン等の無機又は有機物が使用され、その他の無
機塩類として、カリウム、マグネシウム、リン
酸、亜鉛、鉄、マンガン、銅、カルシウム等の各
塩類が使用される。また微量栄養素として、必要
に応じて酵母エキス、肉エキス、コーンスチープ
リカー、ビタミン類、核酸類、アミノ酸類等を添
加してもよい。
The carbon source added to the nutrient medium when culturing basidiomycetes in the present invention may be any carbon source as long as it can be assimilated, such as glucose,
Sugars such as sucrose, molasses, sulfite, pulp waste liquid, and wood saccharification liquid; Organic acids such as acetic acid and citric acid; Alcohols such as methanol and ethanol;
Liquid hydrocarbons, oils and fats, glycerin, etc. can be used. Inorganic or organic substances such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonia, urea, peptone, and casein are used as nitrogen sources, and other inorganic salts include potassium, magnesium, phosphoric acid, zinc, iron, manganese, copper, Various salts such as calcium are used. Further, as micronutrients, yeast extract, meat extract, corn steep liquor, vitamins, nucleic acids, amino acids, etc. may be added as necessary.

培養は好気的条件下に行なうことが望ましく、
一般に通気撹拌培養、振盪培養を行なうのが有利
である。培養温度は15〜35℃で行ない得るが特に
25〜33℃が好ましく、培養液のPHは5〜8.5で行
ない得るが特に6〜8が好ましい。また培養時間
は24〜72時間程度を要する。さらに培養状態によ
つては、シリコーン樹脂、脂肪酸誘導体等の消泡
剤を適宜添加してもよい。
It is preferable to culture under aerobic conditions.
Generally, it is advantageous to carry out aerated agitation culture or shaking culture. Cultivation can be carried out at a temperature of 15 to 35°C, but especially
The temperature is preferably 25 to 33°C, and the pH of the culture solution may be 5 to 8.5, but 6 to 8 is particularly preferred. Moreover, the culture time requires about 24 to 72 hours. Furthermore, depending on the culture conditions, antifoaming agents such as silicone resins and fatty acid derivatives may be added as appropriate.

菌体からのCoQ10の抽出は常法にしたがつて行
なうことができ、例えばピロガロールの存在下に
メタノール性あるいはエタノール性アルカリでケ
ン化し、ケン化液からn−ヘキサン、n−ヘプタ
ン、石油エーテル等の水と混合しない有機溶媒に
CoQ10を転溶させる。さらに精製する場合は、本
抽出物をフロリジル、シリカゲル、アルミナ等を
用いる吸着クロマトグラフイーあるいは薄層クロ
マトグラフイー等により分別精製することができ
る。菌体より単離したCoQ10は薄層クロマトグラ
フイー、紙クロマトグラフイー融点測定、元素
分析、赤外および紫外吸収スペクトル等の各種分
析手段を用いて同定した。またCoQ10の定量方法
としてはレツドフアーンの方法〔メソズ・イン・
エンザイモロジー(Methods in Enzymology)
第10巻、381頁 1967年〕を用いた。
Extraction of CoQ 10 from bacterial cells can be carried out in a conventional manner, for example by saponifying with methanol or ethanolic alkali in the presence of pyrogallol, and extracting n-hexane, n-heptane, petroleum ether from the saponified solution. In organic solvents that are immiscible with water, such as
Transfer CoQ 10 . For further purification, this extract can be fractionated and purified by adsorption chromatography or thin layer chromatography using florisil, silica gel, alumina, or the like. CoQ 10 isolated from bacterial cells was identified using various analytical methods such as thin layer chromatography, paper chromatography melting point measurement, elemental analysis, and infrared and ultraviolet absorption spectra. In addition, as a method for quantifying CoQ 10 , the method of Rezdfan [Methods in
Methods in Enzymology
Volume 10, page 381, 1967] was used.

以上のように本発明方法は、微生物を利用して
CoQ10を製造するのに際し、従来CoQ10生産能を
有していることが認められていなかつた公低担子
菌を利用したものであるが、該担子菌を利用する
ことにより、短期間に、収率良く、多量のCoQ10
を製造しうるという効果が生じる。
As described above, the method of the present invention utilizes microorganisms.
To produce CoQ 10 , we used a basidiomycete that had not been previously recognized to have the ability to produce CoQ 10 , but by using this basidiomycete, we were able to Good yield and large amount of CoQ 10
This has the effect that it is possible to manufacture

また、担子菌類を利用して化合物を製造する場
合、従来は培地に炭素源としてグルコース等の糖
類を使用していたが、本発明方法ではCoQ10を生
産するのに炭素源として前述したような種々の物
質を使用することができる。しかも、培養時に非
糖類炭素源を使用した場合には、炭素源にグルコ
ースを使用した場合よりもCoQ10の収率が良いと
いう効果がある。
In addition, when producing compounds using basidiomycetes, sugars such as glucose were conventionally used as carbon sources in the culture medium, but in the method of the present invention, the above-mentioned carbon sources are used to produce CoQ 10 . A variety of materials can be used. Moreover, when a non-saccharide carbon source is used during culture, the yield of CoQ 10 is better than when glucose is used as a carbon source.

次に、本発明を実施例を挙げて具体的に説明す
るが、本発明はこれらに限定されるものではな
い。
Next, the present invention will be specifically explained with reference to Examples, but the present invention is not limited thereto.

実施例 1 グルコース20g、硫酸アンモニウム1g、リン
酸1カリ1g、硫酸マグネシウム7水塩0.5g、
硫酸第1鉄7水塩5mg、ポリペプトン3g、酵母
エキス1gを1の水道水に溶解して培地とし
た。この培地5を調整し、PHを7.0としたの
ち、10容のジヤーフアーメンターに注入し、
121℃で12分間殺菌した。上記と同一組成の培地
を用い坂口フラスコで前培養したウスチラゴ・シ
ノドンテイスIFO−9758を上記のジヤーフアーメ
ンターに接種し、培養温度30℃、1VVMの通気量
で撹拌速度500rpmにて培養を行なつた。35時間
培養したのち遠心分離機にて集菌し、生菌体510
g(乾物換算46.4g)を得た。
Example 1 20g glucose, 1g ammonium sulfate, 1g potassium phosphate, 0.5g magnesium sulfate heptahydrate,
A culture medium was prepared by dissolving 5 mg of ferrous sulfate heptahydrate, 3 g of polypeptone, and 1 g of yeast extract in 1 part of tap water. After adjusting this medium 5 and setting the pH to 7.0, it was poured into a 10-volume jar fermenter.
Sterilized at 121°C for 12 minutes. Ustilago synodonteis IFO-9758, which had been precultured in a Sakaguchi flask using a medium with the same composition as above, was inoculated into the above jar fermenter, and cultured at a culture temperature of 30°C, an aeration rate of 1 VVM, and a stirring speed of 500 rpm. Ta. After culturing for 35 hours, the bacteria were collected using a centrifuge, and 510 viable bacteria were collected.
g (46.4 g in terms of dry matter) was obtained.

次に前記の生菌体100gを、20mlの水に懸濁
し、これにメタノール200ml、ピロガロール10
g、60%苛性ソーダー10mlを加え、85℃で1時間
加熱還流後400mlの水を加えて冷却したのち、n
−ヘキサン200mlを加えて2回抽出を行なつた。
n−ヘキサン層を100mlの水で3回洗浄し、有機
溶媒層に無水芒硝を加えて脱水後エバポレーター
にてn−ヘキサンを留去した。
Next, suspend 100 g of the above-mentioned live bacterial cells in 20 ml of water, add 200 ml of methanol and 10 ml of pyrogallol.
g, 10 ml of 60% caustic soda was added, heated under reflux at 85°C for 1 hour, cooled by adding 400 ml of water, and then
- Extraction was carried out twice by adding 200 ml of hexane.
The n-hexane layer was washed three times with 100 ml of water, and after dehydration by adding anhydrous sodium sulfate to the organic solvent layer, the n-hexane was distilled off using an evaporator.

残渣に20mlのアセトンを添加し、過後アセト
ンを留去し乾燥した。この乾燥物をn−ヘキサン
に再度溶解し、アルミナカラムにかけ、カラムを
はじめに2%の、ついで4%のエチルエーテルを
含むn−ヘキサン溶液各々100mlで洗浄したの
ち、5%のエチルエーテルを含むn−ヘキサン溶
液を用いて溶出させた。溶出後、CoQ10含有画分
を合し、減圧濃縮したのち、乾固物を5mlのエタ
ノールに溶解させた。
20 ml of acetone was added to the residue, and then the acetone was distilled off and dried. The dried product was redissolved in n-hexane, applied to an alumina column, and the column was first washed with 100 ml each of n-hexane solutions containing 2% and then 4% ethyl ether. - Elution was carried out using a hexane solution. After elution, the CoQ 10- containing fractions were combined and concentrated under reduced pressure, and the dried product was dissolved in 5 ml of ethanol.

この溶解物を冷室に放置して、黄色の粗結晶23
mgを得た。
Leave this melt in a cold room to produce yellow coarse crystals23
I got mg.

この粗結晶にエタノールからの再結操作を2回
実施して12mgの黄色板状結晶を得た。CoQ10の同
定は、薄層クロマトグラフ法、元素分析値、融
点、紫外吸収スペクトル、質量分析値より確認し
た。
The crude crystals were subjected to two reconsolidation operations from ethanol to obtain 12 mg of yellow plate-like crystals. The identity of CoQ 10 was confirmed by thin layer chromatography, elemental analysis, melting point, ultraviolet absorption spectrum, and mass spectrometry.

実施例 2 実施例1と同一の組成を有する培地にウスチラ
ゴ・エスクレンタIFO−9887を培養し、生菌体
407g(乾燥菌体換算37g)を得た。これを実施
例1と同様の方法で抽出し、精製し8mgのCoQ10
を得た。
Example 2 Ustilago esculenta IFO-9887 was cultured in a medium having the same composition as in Example 1, and viable cells were grown.
407g (37g in terms of dry bacterial cells) was obtained. This was extracted and purified in the same manner as in Example 1, and 8 mg of CoQ 10
I got it.

実施例 3 実施例1と同一の組成を有する培地にウスチラ
ゴ・マイデイスIFO−6907を培養し、生菌体330
g(乾燥菌体換算30g)を得た。これを実施例1
と同様の方法で抽出精製し15mgのCoQ10を得た。
Example 3 Ustilago mayidas IFO-6907 was cultured in a medium having the same composition as in Example 1, and 330 viable cells were grown.
g (30 g in terms of dry bacterial cells) was obtained. Example 1
15 mg of CoQ 10 was obtained by extraction and purification in the same manner as above.

実施例 4 実施例1と同一の組成を有する培地にウスチラ
ゴ・クサノイIFO−9070を培養し、生菌体264g
(乾燥菌体換算24g)を得た。これを実施例1と
同様の方法で抽出精製し、6mgのCoQ10を得た。
Example 4 Ustilago cusanoi IFO-9070 was cultured in a medium having the same composition as in Example 1, and 264 g of viable bacterial cells were grown.
(24 g in terms of dry bacterial cells) was obtained. This was extracted and purified in the same manner as in Example 1 to obtain 6 mg of CoQ 10 .

実施例 5 実施例1と同一の組成を有する培地にウスチラ
ゴ・ラベンホルスチアナIFO−8995を培養し、生
菌体374g(乾燥菌体換算34g)を得た。これを
実施例1と同様の方法で抽出精製し8mgのCoQ10
を得た。
Example 5 Ustilago labenhorstiana IFO-8995 was cultured in a medium having the same composition as in Example 1 to obtain 374 g of viable cells (34 g in terms of dry cells). This was extracted and purified in the same manner as in Example 1 to obtain 8 mg of CoQ 10
I got it.

実施例 6 ウスチラゴ・マイデイスIFO−6907を実施例1
で用いた培地組成のグルコースをヘキサデカン20
ml/に置き換えた培地で実施例1に示した培養
条件下、72時間培養し生菌体297g(乾燥菌体換
算27g)を得た。これを実施例1と同様の方法で
抽出精製し、20mgのCoQ10を得た。
Example 6 Ustilago mayidas IFO-6907 in Example 1
Medium composition used in glucose and hexadecane 20
The cells were cultured for 72 hours under the culture conditions shown in Example 1 using the medium replaced with ml/ml, and 297 g of viable cells (27 g in terms of dry cells) were obtained. This was extracted and purified in the same manner as in Example 1 to obtain 20 mg of CoQ 10 .

実施例 7 ウスチラゴ・ラベンホルスチアナIFO−8995を
実施例1で用いた培地組成のグルコースをエタノ
ールに置き換えた培地で実施例1に示した培養条
件下でエタノール濃度を0.5%以下に保ちながら
最終濃度3%になるよう培養を行ない、生菌体
220g(乾燥菌体換算20g)を得た。これを実施
例1と同様の方法で抽出精製し、12mgのCoQ10
得た。
Example 7 Ustilago labenhorstiana IFO-8995 was cultured under the culture conditions shown in Example 1 using a medium in which the glucose in the medium composition used in Example 1 was replaced with ethanol, while maintaining the ethanol concentration at 0.5% or less. Culture to 3%, live bacteria
220 g (20 g in terms of dry bacterial cells) was obtained. This was extracted and purified in the same manner as in Example 1 to obtain 12 mg of CoQ 10 .

Claims (1)

【特許請求の範囲】 1 ウスチラゴ属に属し、補酵素Q10を生産する
能力を有する担子菌を栄養培地に培養して、補酵
素Q10を生成せしめ、得られた菌体よりこれを採
取することを特徴とする発酵法による補酵素Q10
の製造法。 2 ウスチラゴ属に属し、補酵素Q10の生産能を
有する担子菌がウスチラゴ・シノドンテイス
(Ustilago cynodontis)IFO−9758、ウスチラ
ゴ・エスクレンタ(Ustilagoesculenta)IFO−
9887、ウスチラゴ・マイデイス(Ustilago
mydis)IFO−6907、ウスチラゴ・クサノイ
(Ustilago kusanoi)IFO−9070およびウスチラ
ゴ・ラベンホルスチアナ(Ustilago
rabenhorstiana)IFO−8995よりなる群から選ば
れた担子菌である特許請求の範囲第1項記載の補
酵素Q10の製造法。 3 栄養培地の炭素源が糖類、有機酸類、アルコ
ール類、炭化水素類、脂肪酸、油脂またはグリセ
リンである特許請求の範囲第1項または第2項記
載の補酵素Q10の製造法。
[Claims] 1. Cultivating a basidiomycete belonging to the genus Ustilago and having the ability to produce coenzyme Q 10 in a nutrient medium to produce coenzyme Q 10 , and collecting it from the resulting bacterial cells. Coenzyme Q 10 produced by fermentation method characterized by
manufacturing method. 2 Basidiomycetes that belong to the genus Ustilago and have the ability to produce coenzyme Q 10 are Ustilago cynodontis IFO-9758 and Ustilago esculenta IFO-
9887, Ustilago Maydeis
mydis) IFO-6907, Ustilago kusanoi IFO-9070 and Ustilago labenhorstiana (Ustilago kusanoi)
rabenhorstiana) IFO-8995, the method for producing coenzyme Q 10 according to claim 1. 3. The method for producing coenzyme Q 10 according to claim 1 or 2, wherein the carbon source of the nutrient medium is saccharides, organic acids, alcohols, hydrocarbons, fatty acids, fats and oils, or glycerin.
JP2676280A 1980-03-05 1980-03-05 Production of coenzyme q10 through fermentation Granted JPS56124390A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2676280A JPS56124390A (en) 1980-03-05 1980-03-05 Production of coenzyme q10 through fermentation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2676280A JPS56124390A (en) 1980-03-05 1980-03-05 Production of coenzyme q10 through fermentation

Publications (2)

Publication Number Publication Date
JPS56124390A JPS56124390A (en) 1981-09-30
JPS6244915B2 true JPS6244915B2 (en) 1987-09-24

Family

ID=12202291

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2676280A Granted JPS56124390A (en) 1980-03-05 1980-03-05 Production of coenzyme q10 through fermentation

Country Status (1)

Country Link
JP (1) JPS56124390A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01138911U (en) * 1988-03-04 1989-09-22

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01138911U (en) * 1988-03-04 1989-09-22

Also Published As

Publication number Publication date
JPS56124390A (en) 1981-09-30

Similar Documents

Publication Publication Date Title
US5128261A (en) Natural delta-lactones and process of the production thereof
US4220719A (en) Process for the production of Coenzyme Q10
DE2445581C3 (en) Process for the preparation of D-gluconic acid-dlactam
JPS6244915B2 (en)
JPS5923794B2 (en) Manufacturing method of dihydroxyacetone
JP3030916B2 (en) Method for producing β-glucooligosaccharide
JPS5953838B2 (en) Method for producing β-hydroxyvaleric acid
JPH0838188A (en) Production of inositol and method for taking glucose metabolism antagonistic substance-resistant strain
JP2797295B2 (en) Novel microorganism and method for producing menaquinone-4 using the novel microorganism
JPS5953839B2 (en) Method for producing (−)-α-hydroxymethylbutyric acid
JPS5857156B2 (en) Production method of coenzyme Q↓1↓0 by fermentation method
JPS63258586A (en) Production of pyruvic acid by fermentation
JPS6016594A (en) Preparation of menaquinone 6 by bacterium
JPH1042860A (en) Production of inositol and acquirement of hexachlorocyclohexane-resistant strain
JP3747640B2 (en) Process for producing optically active 1,2-diol cyclic carbonate
JP2631867B2 (en) Method for producing (R) -2-hydroxy-4-phenyl-3-butenoic acid
JPH1042883A (en) Production of inositol and collection of strain resistant to 6-halogeno-6-deoxyglucose
JPS5857155B2 (en) Production method of coenzyme Q↓1↓0 by fermentation method
JP2901458B2 (en) Method for producing gentianose
JPS6112677B2 (en)
JPS5926274B2 (en) Production method of coenzyme Q↓1↓0 by fermentation method
JPS5921600B2 (en) Method for producing D(-)-β-hydroxyisobutyric acid
JPS5857157B2 (en) Production method of coenzyme Q↓1↓0 by fermentation method
JPS6251598B2 (en)
JPS5830038B2 (en) Production method of coenzyme Q↓1↓0